References and Notes
<A NAME="RU03708ST-1">1</A> For a review, see:
Bräse S.
Gil C.
Knepper K.
Bioorg. Med.
Chem.
2002,
10:
2415
<A NAME="RU03708ST-2">2</A>
Steffan RJ.
Matelan E.
Ashwell MA.
Moore WJ.
Solvibile WR.
Trybulski E.
Chadwick CC.
Chippari S.
Kenney T.
Eckert A.
Borges-Marcucci L.
Keith JC.
Xu Z.
Mosyak L.
Harnish DC.
J. Med. Chem.
2004,
47:
6435
<A NAME="RU03708ST-3">3</A>
Lien J.-C.
Lee F.-Y.
Huang L.-J.
Pan S.-L.
Guh J.-H.
Teng C.-M.
Kuo SC.
J.
Med. Chem.
2002,
45:
4947
<A NAME="RU03708ST-4">4</A>
Lee F.-Y.
Lien J.-C.
Huang L.-J.
Huang T.-M.
Tsai
S.-C.
Teng C.-M.
Wu C.-C.
Cheng F.-C.
Kuo S.-C.
J.
Med. Chem.
2001,
44:
3746
<A NAME="RU03708ST-5">5</A>
Goodman KB.
Cui H.
Dowdell SE.
Gaitanopoulos DE.
Ivy RL.
Sehon CA.
Stavenger RA.
Wang GZ.
Viet AQ.
Xu W.
Ye G.
Semus SF.
Evans C.
Fries HE.
Jolivette LJ.
Kirkpatrick RB.
Dul E.
Khandekar SS.
Yi T.
Jung DK.
Wright LL.
Smith GK.
Behm DJ.
Bentley R.
Doe CP.
Hu E.
Lee D.
J.
Med. Chem.
2007,
50:
6
<A NAME="RU03708ST-6">6</A>
Song JJ.
Yee NK.
Org. Lett.
2000,
2:
519
<A NAME="RU03708ST-7">7</A>
Correa A.
Tellitu I.
Domínguez E.
SanMartin R.
J. Org. Chem.
2006,
71:
3501
<A NAME="RU03708ST-8">8</A>
Viña D.
Del Olmo E.
López-Pérez JL.
San Feliciano A.
Org.
Lett.
2007,
9:
525
<A NAME="RU03708ST-9">9</A>
Counceller CM.
Eichman CC.
Wray BC.
Stambuli JP.
Org.
Lett.
2008,
10:
1021
<A NAME="RU03708ST-10">10</A>
Liu Z.
Shi F.
Martinez PDG.
Raminelli C.
Larock RC.
J.
Org. Chem.
2008,
73:
219
<A NAME="RU03708ST-11A">11a</A>
Mills AD.
Nazer MZ.
Haddadin MJ.
Kurth MJ.
J. Org. Chem.
2006,
71:
2687
For some other references for the synthesis of indazolone
analogues, see:
<A NAME="RU03708ST-11B">11b</A>
Baiocchi L.
Corsi G.
Palazzo G.
Synthesis
1978,
633
<A NAME="RU03708ST-11C">11c</A>
Barton DHR.
Lukacs G.
Wagle D.
J. Chem. Soc., Chem. Commun.
1982,
450
<A NAME="RU03708ST-11D">11d</A>
Wyrick SD.
Voorstad J.
Cocolas G.
Hall IH.
J.
Med. Chem.
1984,
27:
768
<A NAME="RU03708ST-11E">11e</A>
Bruneau P.
Delvare C.
J. Med. Chem.
1991,
34:
1028
<A NAME="RU03708ST-12A">12a</A> For
a recent example for copper-catalyzed intramolecular C-N
coupling reaction, see:
Lu H.
Li C.
Org. Lett.
2006,
8:
5365
<A NAME="RU03708ST-12B">12b</A> During the preparation
of this manuscript, Zhu and co-workers disclosed their studies on
the synthesis of 2-aryl-2H-indazoles
via copper(I)-catalyzed intramolecular amination reaction of N′-aryl-N′-(o-bromobenzyl) acetyl-hydrazines, but
the reaction need higher reaction tempera-ture (100-105 ˚C)
and long reaction time (20 h) in a pressure tube. See:
Liu R.
Zhu Y.
Qin L.
Ji S.
Katayama S.
Heterocycles
2007,
71:
1755
<A NAME="RU03708ST-13">13</A>
The acid hydrazides were synthesized
from corresponding acid chloride with hydrazine or the condensation
of
2-halobenzoic acid with hydrazine using EDC.
<A NAME="RU03708ST-14A">14a</A>
Zhang H.
Cai Q.
Ma D.
J. Org. Chem.
2005,
70:
5164
<A NAME="RU03708ST-14B">14b</A>
Ma D.
Cai Q.
Zhang H.
Org.
Lett.
2003,
5:
2453
<A NAME="RU03708ST-15">15</A>
Selwood DL.
Brummell DG.
Budworth J.
Burtin GE.
Campbell RO.
Chana SS.
Charles IG.
Fernandez PA.
Glen RC.
Goggin MC.
Hobbs AJ.
Kling MR.
Liu Q.
Madge DJ.
Meillerais S.
Powell KL.
Reynolds K.
Spacey GD.
Stables JN.
Tatlock MA.
Wheeler KA.
Wishart G.
Woo C.-K.
J. Med. Chem.
2001,
44:
78
<A NAME="RU03708ST-16">16</A> For a recent example for copper-catalyzed
C-N coupling reactions at room temperature, see:
Shafir A.
Buchwald
SL.
J.
Am. Chem. Soc.
2006,
128:
8742
<A NAME="RU03708ST-17">17</A>
Xie X.
Chen Y.
Ma D.
J. Am. Chem.
Soc.
2006,
128:
16050
<A NAME="RU03708ST-18">18</A>
Typical Experimental
Procedure - Synthesis of 1-
tert
-butyl-1,2-dihydroindazol-3-one
The
mixture of 2-iodobenzoic acid N′-tert-butylhydrazide (0.32 g, 1.0 mmol),
CuI (19 mg, 0.10 mmol, 10 mol%), l-proline
(23 mg, 0.20 mmol, 20 mol%), and K2CO3 (0.28
g, 2.0 mmol) in DMSO (10 mL) was stirred at r.t. for 3 h under nitrogen
atmosphere. The mixture was treated with H2O and the
mixture was extracted three times with EtOAc. The combined organic
layer was washed with H2O and brine, and dried over MgSO4.
After filtration, solvent was evaporated in vacuo to ca. 1 mL and
crystallization afforded 1-tert-butyl-1,2-dihydroindazole-3-one
(0.19 g, 97%) as white crystals. R
f
= 0.36
(hexane-EtOAc, 1:1); mp 115-117 ˚C. IR (KBr):
2979 (NH), 1648 (C=O), 1538, 1209, 748 cm-¹. ¹H NMR
(400 MHz, DMSO): δ = 10.47 (br s, 1 H, NH), 7.61
(d, 1 H, J = 8.5
Hz, C-4), 7.59 (d, 1 H, J = 7.8
Hz, C-7), 7.26 (dd, 1 H, J = 6.8,
8.5, Hz, C-5), 6.96 (dd, 1 H, J = 6.8,
7.8 Hz, C-6), 1.60 (s, 9 H, t-Bu). ¹³C
NMR (136 MHz, DMSO): δ = 152.8, 139.5, 126.4,
120.1, 118.2, 113.9, 111.9, 58.3, 29.3 (3 × C).
ESI-HRMS: m/z calcd for C11H14N2O 191.1179;
found: 191.1182.
<A NAME="RU03708ST-19">19</A>
Acid hydrazide derived from 2,4,6-trichlorophenyl-hydrazine, tert-butylcarbazide, benzoylhydrazine,
and
p-toluenesulfonylhydrazine
did not afford the corresponding indazolone to recover the starting
material even at heating conditions (>100 ˚C).
<A NAME="RU03708ST-20">20</A>
Gordon DW.
Synlett
1998,
1065
<A NAME="RU03708ST-21">21</A>
A variety of compounds possessing
pharmaceutical profile have been prepared from indazolone derivatives,
see ref. 15.